Sumitomo Pharma Co., Ltd.

TSE:4506.T

606 (JPY) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income -314,969-96,71440,60036,82935,91848,62753,44847,21739,56033,75534,70918,15816,32725,04931,42332,16825,59122,60515,3776,924
Depreciation & Amortization 37,76541,26338,34822,67317,36513,97612,88718,61720,26519,22626,77635,08540,23244,62718,64811,45511,87012,0088,9015,233
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -95,84734,878-33,73366,327-20,852-13,82315,5206,72212,20912,991-6,930-1,380-72-5,859-10,1392,642-436-307-10,7314,891
Accounts Receivables 23,39051,218-6,097185-16,374-3,630-2,934-4,065-6,78613,008-15,1136,80600000000
Inventory -11,7954,5605,356-10,039-14,354-3,207-4,382-9,266-3,026-7904,919-3,731-2,5848,1602,871-5,986-2,102-838-3,3495,591
Accounts Payables 5,6455,318-28,669-32015,241-10,86910,4937,1032,19000000000000
Other Working Capital -113,087-26,218-4,32376,501-5,3653,88319,90215,98815,23513,781-11,8492,3512,512-14,019-13,0108,6281,666531-7,382-700
Other Non Cash Items 189,44832,510-13,9769,77213,697-6911,565-50,932-22,619-35,721-4,612-1,949-8,105-8,776-13,250-19,970-4,5163,566-4,462-1,525
Operating Cash Flow -241,89311,93731,239135,60146,12848,71193,42021,62449,41530,25149,94349,91448,38255,04126,68226,29532,50937,8729,08515,523
Investing Activities:
Investments In Property Plant And Equipment -15,730-12,742-13,494-10,806-13,351-12,914-12,354-13,459-9,740-12,366-21,556-10,025-8,851-9,146-6,129-16,836-9,644-9,758-4,573-3,639
Acquisitions Net 9,03930,172-3,70115,923-205,7741,6939,423-84,348-1,265-729-2,825-24,852-192-91524,111-13,211-2,532-2,2622,3871,133
Purchases Of Investments -4,772-6,247-25,905-9,366-112,494-2,778-6,226-356-297-36,024-51,596-47,418-38,974-14,101-202,484-5,457-6,509-5,259-1,573-674
Sales Maturities Of Investments 34,49910,06819,4728,1411,623-1,693318,93524,88250,82150,00340,41441,52716,06727,5662,0006,9541,0003,8876,917
Other Investing Activites 10,00031,1685,3504,98317,312-19,357-7,39729,4992,30721,745-234-13,1392,1171,5285,09812,238-39,224-3,408-10,575-2,755
Investing Cash Flow 33,03652,419-18,2788,875-312,684-35,049-16,523-59,72915,88723,447-26,208-55,020-4,373-6,567-151,838-21,266-50,955-19,687-10,447982
Financing Activities:
Debt Repayment 84,000-20,060-4,960-24,033250,377-16,460-21,664-22,000-36,529-8,563-20,000-13,000-25,705-13,111139,105-4,600-501-2,059-2,5880
Common Stock Issued 00000000000000000000
Common Stock Repurchased 000000000-3-5-1-1-1-3-92-82-149-155-148
Dividends Paid -2,792-11,125-11,126-11,120-13,106-11,122-7,944-7,151-7,152-7,152-7,152-7,151-7,149-7,149-7,149-7,150-6,357-5,566-1,650-1,651
Other Financing Activities -3,357-115,632-5,340-22,062-6,190-1,063-239,0321,076-7-7-69-67-74-24-2-7-7-2,893-6
Financing Cash Flow 77,851-146,817-21,426-57,215231,081-28,645-29,6109,881-42,605-15,725-27,164-20,221-32,922-20,335131,929-11,844-6,947-7,781-7,286-1,806
Other Information:
Effect Of Forex Changes On Cash 15,44024,09017,7514,729-1134,504-5,115-1,748-8,22510,7037,9504,582-1,775-3,79642937-140041,7850
Net Change In Cash -114,431-59,5069,28691,990-35,588-10,47942,172-29,97212,78148,8752,485-20,7459,31124,7298,658-6,778-25,46310,40433,13714,699
Cash At End Of Period 29,047143,478202,984193,698101,708137,296147,775105,603135,575122,79473,91971,43492,17982,86858,13949,48156,25981,72371,31938,182